354 related articles for article (PubMed ID: 31483689)
1. Effectiveness of Somatic Yoga and Meditation: A Pilot Study in a Multicultural Cancer Survivor Population with Chemotherapy-Induced Peripheral Neuropathy.
Galantino ML; Brooks J; Tiger R; Jang S; Wilson K
Int J Yoga Therap; 2020 Jan; 30(1):49-61. PubMed ID: 31483689
[TBL] [Abstract][Full Text] [Related]
2. Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.
Galantino ML; Tiger R; Brooks J; Jang S; Wilson K
Integr Cancer Ther; 2019; 18():1534735419850627. PubMed ID: 31131640
[TBL] [Abstract][Full Text] [Related]
3. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.
Bao T; Baser R; Chen C; Weitzman M; Zhang YL; Seluzicki C; Li QS; Piulson L; Zhi WI
Oncologist; 2021 Nov; 26(11):e2070-e2078. PubMed ID: 34390283
[TBL] [Abstract][Full Text] [Related]
5. Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial.
Knoerl R; Giobbie-Hurder A; Berfield J; Berry D; Meyerhardt JA; Wright AA; Ligibel JA
J Cancer Surviv; 2022 Aug; 16(4):882-891. PubMed ID: 34524631
[TBL] [Abstract][Full Text] [Related]
6. Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes.
Zhi WI; Baser RE; Zhi LM; Talukder D; Li QS; Paul T; Patterson C; Piulson L; Seluzicki C; Galantino ML; Bao T
Cancer Med; 2021 Aug; 10(16):5456-5465. PubMed ID: 34213086
[TBL] [Abstract][Full Text] [Related]
7. Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial.
Schwenk M; Grewal GS; Holloway D; Muchna A; Garland L; Najafi B
Gerontology; 2016; 62(5):553-63. PubMed ID: 26678611
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing.
Zhi WI; Chen P; Kwon A; Chen C; Harte SE; Piulson L; Li S; Patil S; Mao JJ; Bao T
Breast Cancer Res Treat; 2019 Dec; 178(3):587-595. PubMed ID: 31456070
[TBL] [Abstract][Full Text] [Related]
9. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study.
Prinsloo S; Novy D; Driver L; Lyle R; Ramondetta L; Eng C; McQuade J; Lopez G; Cohen L
Cancer; 2017 Jun; 123(11):1989-1997. PubMed ID: 28257146
[TBL] [Abstract][Full Text] [Related]
11. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB
J Natl Compr Canc Netw; 2023 Feb; 21(2):125-132.e3. PubMed ID: 36791763
[TBL] [Abstract][Full Text] [Related]
13. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
14. Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial.
Bao T; Zhi I; Baser R; Hooper M; Chen C; Piulson L; Li QS; Galantino ML; Blinder V; Robson M; Seidman A; Panageas KS; Mao JJ
JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa048. PubMed ID: 33225208
[TBL] [Abstract][Full Text] [Related]
15. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.
Ajewole VB; Cox JE; Swan JT; Chikermane SG; Lamoth B; Iso T; Okolo LO; Ford CL; Schneider AM; Hobaugh EC; Baker KR
Support Care Cancer; 2020 Apr; 28(4):1901-1912. PubMed ID: 31359183
[TBL] [Abstract][Full Text] [Related]
16. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
17. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.
Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S
J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243
[TBL] [Abstract][Full Text] [Related]
18. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
[TBL] [Abstract][Full Text] [Related]
19. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB
Support Care Cancer; 2019 Oct; 27(10):3849-3857. PubMed ID: 30756229
[TBL] [Abstract][Full Text] [Related]
20. Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Cao A; Cartmel B; Li FY; Gottlieb LT; Harrigan M; Ligibel JA; Gogoi R; Schwartz PE; Esserman DA; Irwin ML; Ferrucci LM
JAMA Netw Open; 2023 Aug; 6(8):e2326463. PubMed ID: 37526937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
